Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Randomized Clinical Trial
100%
Ketamine
100%
Chronic Post-traumatic Stress Disorder
100%
Intravenous Ketamine
100%
Midazolam
60%
Depressive Symptoms
40%
Posttraumatic Stress Disorder
40%
Disabling Conditions
40%
Rapid Reduction
40%
Ketamine Infusion
40%
Posttraumatic Stress Disorder Symptom Severity
40%
Impact of Event Scale
40%
Chronic Disease
20%
Comorbid
20%
Clinical Presentation
20%
Randomized Double-blind
20%
Placebo-controlled
20%
Adverse Effects
20%
Clinically Significant
20%
Pharmacotherapy
20%
Symptom Severity
20%
Depression Severity
20%
Intravenous Infusion
20%
School of Medicine
20%
Clinical Global Impression
20%
Mount Sinai
20%
Posttraumatic Stress Symptoms
20%
Clinician-administered
20%
Ketamine Hydrochloride
20%
Active Placebo
20%
Effect Measure
20%
Brief Psychiatric Rating Scale
20%
Young Mania Rating Scale
20%
Trauma Exposure
20%
Dissociative State
20%
Period Analysis
20%
Scale Effect
20%
Pharmacologic Treatment
20%
Well Tolerated
20%
Montgomery-Asberg Depression Rating Scale
20%
Secondary Outcome Measures
20%
Dissociative Seizures
20%
Subanesthetic Dose
20%
Medicine and Dentistry
Posttraumatic Stress Disorder
100%
Ketamine
100%
Randomized Clinical Trials
100%
Infusion
33%
Midazolam
33%
Impact of Events Scale
22%
Placebo
11%
Intravenous Drug Administration
11%
Drug Therapy
11%
Clinician
11%
Clinical Global Impression
11%
Montgomery-Åsberg Depression Rating Scale
11%
Stress-Related Disorders
11%
Young Mania Rating Scale
11%
Brief Psychiatric Rating Scale
11%
Depressive Disorder
11%
Adverse Effect
11%
Neuroscience
Posttraumatic Stress Disorder
100%
Ketamine
100%
Midazolam
33%
Dissociative
22%
Placebo
11%
Stress-Related Disorders
11%
Depressive Disorder
11%
Drug Therapy
11%
Adverse Effect
11%